This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Unwin N, Shaw J, Zimmet P, et al. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med. 2002; 19(9):708-23.Search in Google Scholar
American Diabetes Association. Standards of Medical Care in Diabetes – 2017. Diabetes Care. 2017; 40 (Suppl. 1):S1-S135.Search in Google Scholar
Hanefeld M, Koehler C, Fuecker K, et al. Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study. Diabetes Care. 2003; 26(3):868-74.Search in Google Scholar
Meyer C, Pimenta W, Woerle HJ, et al. Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care. 2006; 29(8):1909-14.Search in Google Scholar
McMaster University Evidence Based Practice Center. Diagnosis, prognosis and treatment of impaired glucose tolerance and impaired fasting glucose. Evidence Report 128. 2005.Search in Google Scholar
Chakarova N. Cardiovascular risk in prediabetic conditions – impaired fasting glucose and impaired glucose tolerance [in Bulgarian] Dissertation, 2011, Sofia.Search in Google Scholar
World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Report of a WHO/IDF consultation. Geneva, WHO, 2006.Search in Google Scholar
Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 2018; 39: 3021-3104.Search in Google Scholar
Festa A, D’Agostino R Jr, Hanley AJ, et al. Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose. Diabetes. 2004; 53(6):1549-55.Search in Google Scholar
Nabila S, Kim JE, Choi J, et al. Associations Between Modifiable Risk Factors and Changes in Glycemic Status Among Individuals With Prediabetes. Diabetes Care. 2023; 46(3):535-543. doi: 10.2337/dc22-1042.Search in Google Scholar
Li Z, Kang S, Kang H. Development and validation of nomograms for predicting cardiovascular disease risk in patients with prediabetes and diabetes. Sci Rep. 2024; 14(1):20909. doi: 10.1038/s41598-024-71904-3.Search in Google Scholar
Ishikawa J, Schwartz JE, Pickering TG. Pre-diabetes is Associated with Masked Hypertension. Circulation. 2009; 120:S1060.Search in Google Scholar
Geijerstam PA, Engvall J, Östgren CJ, et al. Home Blood Pressure Compared with Onjce Blood Pressure in Relation to Dysglycemia. Am J Hypertens. 2022; 35(9):810-819.Search in Google Scholar
Kotsis V, Stabouli S, Toumanidis S, et al. Target organ damage in „white coat hypertension“ and „masked hypertension“. Am J Hypertens 2008; 21: 393-399.Search in Google Scholar
Hänninen MR, Niiranen TJ, Puukka PJ, et al. Determinants of masked hypertension in the general population: the Finn-Home study. J Hypertens 2011; 10: 1880-1888.Search in Google Scholar
Gupta AK, Greenway FL, Cornelissen G, et al. Prediabetes is associated with abnormal circadian blood pressure variability. J Hum Hypertens. 2008; 22(9):627-33.Search in Google Scholar
Jug J, Delalić Ð, Bralić Lang V, et al. Prediabetes, Non-Dipping Profile and Hypertension-A Recipe for Increased Arterial Stiffness. Biomedicines. 2023; 11(4):1065. doi: 10.3390/biomedicines11041065.Search in Google Scholar
Obayashi K, Saeki K, Kurumatani N. Nighttime BP in Elderly Individuals with Prediabetes/Diabetes with and without CKD: The HEIJO-KYO Study. Clin J Am Soc Nephrol. 2016; 11(5):867-74.Search in Google Scholar
Kwon BJ, Kim DW, Park MW, et al. Clinical implications of combined glucose intolerance in treatment-naïve hypertensive patients. Clin Exp Hypertens. 2018; 40(8):762-771.Search in Google Scholar
Profil Orcid